
GHRH & GH Secretagogues
CJC-1295 no DAC
Buy 2, get 1 free10mg
$64.99
Welcome to VANTA LABS
Are you 21 or older?
Vanta Labs supplies research materials for laboratory use only. You must be 21 or older to enter.
Research use only. Not for human or veterinary use.

Tesamorelin is a synthetic growth-hormone-releasing hormone (GHRH) analog peptide offered by Vanta Labs as a lyophilized powder for laboratory and in-vitro research. Every batch is independently third-party tested and ships with a Certificate of Analysis confirming >=99% purity, with the lot number matched to its report. For laboratory research use only. Not for human or veterinary consumption; not a drug, food, cosmetic, or dietary supplement, and not intended to diagnose, treat, cure, or prevent any condition.
Molecular Formula: C221H366N72O67S
Purity
99.39%
Batch
Vanta184290
Published batch records
Vanta184290
10mg · 99.39% · Jul 3, 2026 · Horizon Analytical
Frequently Asked Questions
Tesamorelin is a synthetic 44-residue analogue based on human growth hormone-releasing hormone, GHRH(1-44). Its chemical description includes an N-terminal (3E)-hex-3-enoyl modification and a C-terminal leucinamide group. Vanta Labs lists it for laboratory research only.
TH9507 is a development code used as an alternate name for Tesamorelin. It is a searchable synonym, not a separate compound or a different vial presentation.
The Tesamorelin identity listed by Vanta Labs is associated with CAS number 218949-48-5. Tesamorelin acetate is a separately identified salt form and should not be assumed to be the exact form of the listed material without product-specific documentation.
PubChem lists the Tesamorelin molecular formula as C221H366N72O67S. The acetate salt form is described separately and includes acetate counterions, so the formula for the Tesamorelin moiety should not be presented as a complete acetate-salt formula.
The molecular weight is approximately 5135.9 g/mol as the free-base equivalent. PubChem and the Vanta Labs product page round this value to approximately 5136 g/mol. The free-base-equivalent value should not be mistaken for the total mass of an acetate salt form.
The structural description includes a (3E)-hex-3-enoyl group attached to the N-terminal tyrosine and a C-terminal leucinamide group, written as Leu-NH2. These details are important when describing the modified peptide rather than only its residue sequence.
A one-letter amino-acid sequence shows the order of residues but does not fully represent terminal chemical modifications. Sequence notation allows the N-terminal (3E)-hex-3-enoyl group and C-terminal Leu-NH2 to be stated alongside the 44-residue backbone.
The Vanta Labs product page lists Tesamorelin as a lyophilized powder and shows 5 mg and 10 mg vial options. Refer to the selected product variant for the exact presentation associated with an order.
Tesamorelin is listed under CAS 218949-48-5, while Tesamorelin acetate is separately identified under CAS 901758-09-6. The acetate form includes counterions. The presence of a related salt-form identifier in a reference database does not establish that a particular product listing is supplied in that salt form.
Compound identity testing assesses whether a sample is consistent with the named compound. Analytical purity reports the detected signal distribution under a specified analytical method. A purity figure does not replace identity testing, and neither establishes sterility or other attributes that were not tested.
No. The Vanta Labs listing is presented as a laboratory research material, not as a finished pharmaceutical drug product. Its Research Use Only designation does not represent the listing as an approved medicine or authorize human or veterinary use.
Tesamorelin is identified by CAS number 218949-48-5 and molecular formula C221H366N72O67S, as listed by PubChem (CID 16137828). These identifiers apply to the Tesamorelin moiety, not to the separately identified Tesamorelin acetate salt form.
No. This material is a research chemical, not a drug product. Vanta Labs supplies it for laboratory research only; it is not for human or veterinary use.
No. All compounds sold by Vanta Labs are strictly for legitimate laboratory research purposes and are not intended for human or veterinary use.
Where a batch report has been published, the product page links to it. All published reports are in the COA Library, searchable by batch number.
In-stock orders placed before 2PM ET on a business day are dispatched the same day. Carrier transit time is additional. You will receive secure tracking information after dispatch.
No — exactly one discount applies per order. Promo codes, ambassador codes, bundle pricing, and promotions never combine. You don't have to figure out which is best: checkout automatically applies whichever single discount saves you the most.
Where we ship, damaged or missing items, returns and support are covered in our FAQ.
Tesamorelin is also known by the development code TH9507. Public chemical records identify the compound under CAS 218949-48-5. Vanta Labs uses this CAS number on its product page and lists the molecular formula as C221H366N72O67S. PubChem records the same formula and a computed molecular weight of approximately 5136 g/mol.
Tesamorelin is a synthetic analogue based on the 44-residue sequence of human growth hormone-releasing hormone, GHRH(1-44). Its structural description includes a (3E)-hex-3-enoyl modification attached to the N-terminal tyrosine and a C-terminal leucinamide group, written as Leu-NH2. These modifications are relevant to the complete chemical identity and should not be lost when the compound is described only by its one-letter amino-acid sequence.
For this reason, the identity record uses sequence notation rather than presenting the plain residue string as a complete description of the modified molecule. The sequence notation identifies the 44-residue backbone and states the terminal modifications separately. The official FDA substance record also distinguishes the Tesamorelin active moiety from Tesamorelin acetate as a salt form.
Vanta Labs lists Tesamorelin within its GHRH Analogues and GH Secretagogues category. This is a catalog classification, not a separate chemical identity or product specification.
The product page lists lyophilized powder in 5 mg and 10 mg vial sizes. Refer to the selected product variant and its accompanying product information for the presentation being described. Do not assume that a document associated with one vial size applies to another size unless the product page explicitly links that document to the selected variant.
This page provides neutral product-identification information, including the compound name, established identifiers, structural description, listed presentation, and links to available batch documentation. It does not provide preparation, dosage, administration, or clinical-use instructions. Tesamorelin from Vanta Labs is offered for laboratory research only and is not intended for human or veterinary use.
| Property | Value |
|---|---|
| Product name | Tesamorelin |
| Development code / synonym | TH9507 |
| CAS number | 218949-48-5 |
| Molecular formula | C221H366N72O67S |
| Molecular weight | 5136 g/mol (computed as 5135.9 g/mol for the free-base equivalent, per PubChem) |
| PubChem CID | 16137828 |
| Tesamorelin UNII | MQG94M5EEO |
| Compound type | Synthetic GHRH(1-44) analogue peptide |
| Sequence basis | 44-residue human GHRH(1-44) sequence, with N-terminal (3E)-hex-3-enoyl modification and C-terminal Leu-NH2 |
| Physical form | Lyophilized powder |
| Listed vial sizes | 5 mg and 10 mg |
| Storage information | Follow the temperature and conditions stated on the product label or the applicable Certificate of Analysis. No fixed temperature is specified in this product record. |
Identity note: The formula above corresponds to the Tesamorelin moiety. Tesamorelin acetate is a separately identified salt form and includes acetate counterions. Vanta Labs lists this product under Tesamorelin and CAS 218949-48-5; the listing does not expressly identify the supplied material as the acetate salt.
A compound identity record describes the expected chemical entity. A batch-specific Certificate of Analysis records findings for a particular sample and should be read as a document for the product and vial size it names. The product page displays available batch documentation separately from the general compound specifications. Where no report is linked for a selected size, do not infer that a report for another size applies to it.
A product label and a laboratory report may use different reference numbers when a report was issued under a partner's sample or lot identifier. In that situation, rely on the cross-reference supplied by Vanta Labs and the explanation on the linked report page. Do not assume the two identifiers are identical, and do not treat an unrelated report as evidence for the vial being reviewed.
A Certificate of Analysis may contain separate information about identity and purity. Identity testing assesses whether the analytical finding is consistent with the named compound. A chromatographic purity figure describes the distribution of detected signal under the stated method and conditions. These findings answer different questions and should not be treated as interchangeable.
A reported chromatographic percentage is not, by itself, a measurement of sterility, endotoxin content, residual solvents, heavy metals, water content, or suitability for any human or veterinary use. Do not infer that an unreported test was performed or that a passing figure for one attribute establishes another. For an explanation of report fields and method limits, see How to Read a COA and Testing & Quality.
Vanta Labs' general handling guidance says to keep research materials sealed and protected from light, moisture, and heat, and to follow the temperature stated on the product label or applicable Certificate of Analysis. This product record does not set a universal storage temperature. Retain the product's batch identification with its documentation and follow the laboratory's own chemical-handling and protective-equipment procedures. For the site's general research-material guidance, follow the instructions published on the product label and the applicable Certificate of Analysis.
Vanta Labs supplies this material strictly for laboratory and research purposes. It is not intended for consumption or administration by humans or animals, and it is not intended to diagnose, treat, cure, or prevent any disease or condition. This product page does not make clinical, therapeutic, health, or performance claims.
A Research Use Only designation describes the stated scope of the listing. It does not establish safety, efficacy, regulatory approval, or suitability for any particular laboratory use. Product identity information and batch documentation should be read only within the limits of the cited records. A Certificate of Analysis for one sample or vial size does not establish the properties of another sample or size.
Personnel handling laboratory materials should follow their institution's safety procedures, appropriate protective-equipment requirements, and the storage conditions stated on the product label or applicable documentation. Review the Vanta Labs Research Disclaimer for the complete research-use terms.
Compound
Specifications
44-residue human GHRH(1-44) analogue; N-terminal (3E)-hex-3-enoyl modification on Tyr1; C-terminal leucinamide (Leu-NH2)Tesamorelin acetate is a separately identified salt form (CAS 901758-09-6; UNII LGW5H38VE3). Vanta Labs lists this product as Tesamorelin under CAS 218949-48-5 and does not expressly identify the supplied material as the acetate salt.
Source: PubChem: Tesamorelin, CID 16137828 · FDA Global Substance Registration System: Tesamorelin active moiety · FDA NDA 22-505 Chemistry Review: Tesamorelin and Tesamorelin acetate chemical identity · Vanta Labs: Tesamorelin product page and specifications · FDA Global Substance Registration System: Tesamorelin acetate salt form. Accessed 2026-11-10.
Testing
Certificates of Analysis for the batch currently supplied. Each report is the laboratory's own document for that vial size.
Lot GB-1700427-P · 10 mg
Purity 99.39% (UPLC/MS) · Analysed Jul 3, 2026 · Horizon Analytical
Horizon Analytical reports can be searched by their lot number at horizonanalytical.com.
Browse the COA LibraryOrdering: Shipping policy · Returns and reimbursement · Research use disclaimer
Store reviews · ordering, shipping and service
5.0 average customer rating
“Ordered on a Wednesday morning and wasn't expecting much because it was my first time buying here. Got tracking that afternoon and the package arrived Friday. Honestly faster than I expected lol.”
Vanta Labs customer
“Not gonna lie I accidentally added the wrong item to my cart and didn't realize until after checkout. Sent a message thinking I'd be stuck with it. Support helped me correct it before the package went out. Saved me a headache.”
Vanta Labs customer
“The packaging was actually what impressed me most. I've had glass research supplies arrive with barely any protection before, so seeing everything packed properly was a relief. Little things like that matter.”
Vanta Labs customer
“First time ordering here. The site was easy enough to use, although I had to go back and double check which size I selected. Everything was labeled clearly when it arrived.”
Vanta Labs customer
“Honestly I spent more time comparing options than I did checking out lol. Once I decided what I wanted, the actual order process took maybe two minutes.”
Vanta Labs customer
“Placed an order after a friend mentioned the website. I was a little skeptical because I hadn't heard of them before, but the ordering experience was straightforward and the communication was good. Everything came fast and will buy again.”
Vanta Labs customer
Sent to us by customers by email; names withheld. Reviews describe ordering, shipping and service.
Related Products
Blog